Meteora Capital’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-189,507
Closed -$22.8K – 470
2026
Q1
$22.8K Sell
189,507
-25,994
-12% -$5.95K ﹤0.01% 284
2025
Q4
$60.3K Buy
215,501
+190,884
+775% +$62.6K 0.01% 246
2025
Q3
$7.14K Buy
+24,617
New +$6.67K ﹤0.01% 263

Other funds holding TDACW

Meteora Capital's TDACW Position: Q2 2026 in Review

Meteora Capital sold out of Translational Development Acquisition Corp Warrants (TDACW) in Q2 2026, closing a stake of 189,507 shares — an estimated $22.8K sold.

Meteora Capital first reported a position in TDACW in Q3 2025 and held it in 3 quarters. The position peaked at $60.3K in Q4 2025. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.

  • Meteora Capital reported no remaining Translational Development Acquisition Corp Warrants position as of Q2 2026 after selling out during the quarter.
  • Meteora Capital sold 189,507 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $22.8K.
  • Meteora Capital first reported a position in Translational Development Acquisition Corp Warrants in Q3 2025 and held it in 3 quarters.
  • Meteora Capital's Translational Development Acquisition Corp Warrants position peaked at $60.3K in Q4 2025.
  • 28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.

Based on Meteora Capital's 13F filing for Q2 2026, filed 14 Aug 2026.